Dimensional Fund Advisors’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,376
Closed -$21.2K 3298
2025
Q1
$21.2K Sell
18,376
-228
-1% -$424 ﹤0.01% 3300
2024
Q4
$114K Hold
18,604
﹤0.01% 3230
2024
Q3
$308K Sell
18,604
-18,430
-50% -$202K ﹤0.01% 3106
2024
Q2
$254K Sell
37,034
-2,419
-6% -$20.7K ﹤0.01% 3132
2024
Q1
$381K Hold
39,453
﹤0.01% 3087
2023
Q4
$328K Sell
39,453
-720
-2% -$4.18K ﹤0.01% 3114
2023
Q3
$335K Sell
40,173
-12,080
-23% -$102K ﹤0.01% 3118
2023
Q2
$482K Sell
52,253
-42,739
-45% -$479K ﹤0.01% 3073
2023
Q1
$1.31M Buy
94,992
+49,315
+108% +$1.02M ﹤0.01% 2845
2022
Q4
$777 Buy
45,677
+8
+0% +$160 ﹤0.01% 2959
2022
Q3
$1.04M Sell
45,669
-26,481
-37% -$535K ﹤0.01% 2871
2022
Q2
$1.3M Buy
72,150
+15,951
+28% +$284K ﹤0.01% 2862
2022
Q1
$1.5M Sell
56,199
-2,022
-3% -$37.6K ﹤0.01% 2893
2021
Q4
$1.71M Buy
58,221
+50,848
+690% +$2.53M ﹤0.01% 2888
2021
Q3
$485K Sell
7,373
-480
-6% -$36.7K ﹤0.01% 3190
2021
Q2
$653K Buy
+7,853
New +$582K ﹤0.01% 3105

Other funds holding IGMS

Dimensional Fund Advisors's IGMS Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 18,376 shares — an estimated $21.2K sold.

Dimensional Fund Advisors first reported a position in IGMS in Q2 2021 and held it in 16 quarters. The position peaked at $1.71M in Q4 2021. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 18,376 IGM Biosciences shares in Q2 2025, an estimated $21.2K.
  • Dimensional Fund Advisors first reported a position in IGM Biosciences in Q2 2021 and held it in 16 quarters.
  • Dimensional Fund Advisors's IGM Biosciences position peaked at $1.71M in Q4 2021.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.